Alembic Pharmaceuticals Limited
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported 8.80 INR per share, beating the 7.79 INR estimate by 13.00%. Revenue for the same period reached 21.50 B INR, despite the estimate of 18.81 B INR. For the next quarter, analysts expect 11.50 INR in earnings per share and 22.22 B INR in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise